Orchid Pharma Limited announced that it has received INR 3.999999631 billion in funding from MITIMCo Private Equity, Quant Capital Finance & Investments Private Limited, Asset Management Arm, carnelian structural shift fund, 238 Plan Associates LLC, Societe Generale Industrielle de Filtration S.A. and other investor

On June 27, 2023, Orchid Pharma Limited closed the transaction. The transaction approval from board of directors with respect to the transaction. The company issued shares to 2,351,893 shares to MITIMCo Private Equity, 1,262,596 shares to quant Mutual Fund - quant Multi Asset Fund, a fund managed by Quant Capital Finance & Investments Private Limited, Asset Management Arm, 668,432 shares to Quant Money Managers Limited - Quant Mutual Fund - Quant Value Fund,a fund managed by Quant Capital Finance & Investments Private Limited, Asset Management Arm, 618,919 shares to carnelian structural shift fund, 618,919 shares to 238 Plan Associates LLC, 594,162 shares to Societe Generale Industrielle de Filtration S.A. The investors here are only top 6 investors disclosed by the company.